MedTrace Logo

Geko™ Cross Therapy Registry - Wound

NCT05007301 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 2500

Last updated 2024-03-01

No results posted yet for this study

Summary

The geko™ Cross Therapy REGISTRY - Wound is a prospective, observational, anonymised data collection Registry with no experimental treatment that will fulfil an unmet need for an observational Registry to provide long-term clinical data to demonstrate patient benefit and regulatory compliance.

Conditions

  • Wound
  • Venous Leg Ulcer
  • Diabetic Foot Ulcer
  • Arterial Leg Ulcer

Interventions

DEVICE

geko device

Neuromuscular electrostimulation of the peroneal nerve, 12h per day, for up to 12 weeks.

Sponsors & Collaborators

  • Firstkind Ltd

    lead INDUSTRY

Principal Investigators

  • Agnes Collarte · Central London Community Health Care NHS Trust

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-04-04
Primary Completion
2027-09-30
Completion
2028-03-31
FDA Device
Yes

Countries

  • United States
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05007301 on ClinicalTrials.gov